Dr. Patrick Jackson, an infectious disease expert at the University of Virginia said Pfizer’s announcement Thursday is promising, but expected. “I hope this will make people hesitate less,” said Jackson. “I don’t think this finding was very surprising. It was what we’d hoped to see, but certainly, it was on the stronger side of what we were hoping for.”